Trial
NCT06502990
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Amryt Pharma
Collaborators
—
Condition
Generalized Lipodystrophy
Intervention
Metreleptin
Why stopped
This clinical trial was closed early due to no longer being a requirement to the European Medicines Agency.
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-22